[Fibrinolysis in prostate carcinomas of varying grades of differentiation with respect to estrogen therapy and castration].
In 21 patients with histologically ascertained carcinoma of the prostate before the beginning of the oestrogen therapy the rate of fibrinolysis and the time of euglobulinolysis were determined. In more than two thirds of the cases an increased rate of fibrinolysis was found, 4 cases of them showed a shortening of the time of euglobulinolysis. The rate of fibrinolysis was in all 21 patients on an average 61%. In the 12 patients with increased rate of fibrinolysis it was on an average 89%. After the oestrogen therapy a reduction to on an average 49% could be stated.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000503:physiopathology*; D000368:Aged; D002369:Castration; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D012712:Serum Globulins / Q000378:metabolism
D004967:Estrogens; D012712:Serum Globulins
Die Fibrinolyse bei Prostatakarzinomen verschiedener histologischer Differenzierungsgrade unter Berücksichtigung der gegengeschlechtlichen Hormonbehandlung und Kastration.